Conf42: Machine Learning 2025

Revolutionizing Pharmaceutical Operations: How API-Driven Architectures Deliver 60% Faster Time-to-Market

Discover how our API-driven architecture cut mRNA cancer vaccine time-to-market by 60%, achieved 99.1% data validation accuracy, 98% defect detection, and reduced trial duration by 38%—all while ensuring regulatory compliance. Learn strategies to transform pharma operations and drive innovation.